Cocaine Hydrochloride Patent Expiration

1. Goprelto patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9867815 NODEN PHARMA Pharmaceutical compositions and methods of using the same
Feb, 2037

(12 years from now)

US10413505 NODEN PHARMA Pharmaceutical compositions and methods of using the same
Feb, 2037

(12 years from now)

US10149843 NODEN PHARMA Pharmaceutical compositions and methods of using the same
Feb, 2037

(12 years from now)

US10987347 NODEN PHARMA Pharmaceutical compositions and methods of using the same
Feb, 2037

(12 years from now)

US10894012 NODEN PHARMA Pharmaceutical compositions and methods of using the same
Feb, 2037

(12 years from now)

US10857095 NODEN PHARMA Pharmaceutical compositions and methods of using the same
Feb, 2037

(12 years from now)

US10231961 NODEN PHARMA Pharmaceutical compositions and methods of using the same
Feb, 2037

(12 years from now)

US11040032 NODEN PHARMA Pharmaceutical compositions and methods of using the same
Feb, 2037

(12 years from now)

US10016407 NODEN PHARMA Pharmaceutical compositions and methods of using the same
Feb, 2037

(12 years from now)

US10420760 NODEN PHARMA Pharmaceutical compositions and methods of using the same
Feb, 2037

(12 years from now)

US10933060 NODEN PHARMA Pharmaceutical compositions and methods of using the same
Feb, 2037

(12 years from now)

US10973811 NODEN PHARMA Pharmaceutical compositions and methods of using the same
Feb, 2037

(12 years from now)




Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity(NCE) Dec 14, 2022

NCE-1 date: 14 December, 2021

Market Authorisation Date: 14 December, 2017

Treatment: Method of administering a local anesthetic to the mucous membranes in geriatric patients; Method of administering a local anesthetic to the mucous membranes; Method for the induction of local anesthes...

Dosage: SOLUTION

More Information on Dosage

GOPRELTO family patents

Family Patents

2. Numbrino patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10973811 OMNIVIUM PHARMS Pharmaceutical compositions and methods of using the same
Feb, 2037

(12 years from now)

US10894012 OMNIVIUM PHARMS Pharmaceutical compositions and methods of using the same
Feb, 2037

(12 years from now)

US10857095 OMNIVIUM PHARMS Pharmaceutical compositions and methods of using the same
Feb, 2037

(12 years from now)

US10420760 OMNIVIUM PHARMS Pharmaceutical compositions and methods of using the same
Feb, 2037

(12 years from now)

US10413505 OMNIVIUM PHARMS Pharmaceutical compositions and methods of using the same
Feb, 2037

(12 years from now)

US10149843 OMNIVIUM PHARMS Pharmaceutical compositions and methods of using the same
Feb, 2037

(12 years from now)

US10016407 OMNIVIUM PHARMS Pharmaceutical compositions and methods of using the same
Feb, 2037

(12 years from now)

US10933060 OMNIVIUM PHARMS Pharmaceutical compositions and methods of using the same
Feb, 2037

(12 years from now)

US11040032 OMNIVIUM PHARMS Pharmaceutical compositions and methods of using the same
Feb, 2037

(12 years from now)

US10231961 OMNIVIUM PHARMS Pharmaceutical compositions and methods of using the same
Feb, 2037

(12 years from now)

US9867815 OMNIVIUM PHARMS Pharmaceutical compositions and methods of using the same
Feb, 2037

(12 years from now)




Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity(NCE) Dec 14, 2022
New Product(NP) Jan 10, 2023

NCE-1 date: 14 December, 2021

Market Authorisation Date: 10 January, 2020

Treatment: A method for treating a subject with uveal melanoma with unresectable hepatic metastases; Method for the induction of local anesthesia of the mucous membranes; Method for the induction of local anesth...

Dosage: SOLUTION

More Information on Dosage

NUMBRINO family patents

Family Patents